8-K 1 d8k.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2001 DrugMax, Inc. ------------------------------------------------------ (formerly DrugMax.com, Inc.) (Exact name of registrant as specified in its charter) STATE OF NEVADA 1-15445 34-1755390 ---------------------------- ------------------------ ------------------- (State or other jurisdiction (Commission File Number) (IRS Employer of incorporation) Identification No.) 12505 Starkey Road, Suite A Largo, Florida 33773 (Address of principal executive offices) Registrant's telephone number, including area code: (727) 533-0431 Item 5. Other Events. On November 12, 2001, DrugMax, Inc. (the "Company") issued a press release announcing its financial results for the second quarter ended September 30, 2001. A copy of the press release, which is incorporated by reference herein and made a part hereof, is filed with this Current Report on Form 8-K as Exhibit 99. Item 7. Financial Statements and Exhibits. (a) Financial Statements of Business None. (b) Pro Forma Financial Information. None. (c) Exhibits. Exhibit Number Exhibit Description ------- ------------------- 99.1 Press Release, dated November 12, 2001. SIGNATURE --------- Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized. DRUGMAX, INC. By /s/ William L. LaGamba --------------------------------------- William L. LaGamba, President and Chief Operations Officer Dated: November 12, 2001 EXHIBIT INDEX Exhibit Number Exhibit Description ------- ------------------- 99.1 Press Release, dated November 12, 2001.